Nursing Elites

1. The client on clopidogrel (Plavix) should be monitored for which adverse effect?

• A. Bleeding
• B. Hypertension
• C. Tachycardia
• D. Bradycardia

Correct answer: A

Rationale: Correct! Clopidogrel (Plavix) is an antiplatelet medication that helps prevent blood clots. As a side effect, it can increase the risk of bleeding. Monitoring for signs of bleeding, such as easy bruising, blood in urine or stools, or prolonged bleeding from cuts, is crucial. Choices B, C, and D are incorrect as hypertension, tachycardia, and bradycardia are not typically associated with clopidogrel use.

2. The client is on warfarin and has an INR of 1.5. What is the nurse’s priority action?

• A. Increase the dose of warfarin.
• B. Hold the next dose of warfarin.
• C. Continue the current dose of warfarin.
• D. Monitor the client’s INR closely.

Correct answer: B

Rationale: An INR of 1.5 is below the therapeutic range for a client on warfarin, indicating that the client may be at risk of clot formation. The nurse's priority action should be to hold the next dose of warfarin to prevent further reduction of the INR. Increasing the dose could potentially lead to an increased risk of bleeding, and continuing the current dose may not be sufficient to bring the INR within the therapeutic range. Monitoring the client's INR closely is important but not the priority action in this scenario.

3. What is a type of medication that helps to prevent blood clots by thinning the blood?

• A. Anticoagulant
• B. Beta-blocker
• C. ACE inhibitor
• D. Calcium channel blocker

Correct answer: A

Rationale: Anticoagulants are medications specifically designed to prevent blood clots by thinning the blood. They work by interfering with the body's blood clotting process. Beta-blockers, ACE inhibitors, and calcium channel blockers are medications used for different purposes such as managing blood pressure, heart conditions, and regulating heart rhythm, respectively. However, they do not have the primary function of preventing blood clots like anticoagulants.

4. Which chronic condition is characterized by abnormally thickened heart muscle, making it harder for the heart to pump blood efficiently?

• A. Hypertrophic cardiomyopathy
• B. Dilated cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Ventricular hypertrophy

Correct answer: A

Rationale: Hypertrophic cardiomyopathy is the correct answer. In this condition, the heart muscle becomes abnormally thickened, leading to difficulties in pumping blood efficiently. Dilated cardiomyopathy (choice B) involves the enlargement of the heart chambers, not thickening of the heart muscle. Restrictive cardiomyopathy (choice C) is characterized by stiffening of the heart muscle, impairing its ability to fill properly. Ventricular hypertrophy (choice D) refers to the thickening of the heart's ventricle walls, which can result from various conditions, not solely hypertrophic cardiomyopathy.

5. What is a type of heart disease that involves the thickening or stiffening of the heart muscle, reducing its ability to pump blood?

• A. Hypertrophic cardiomyopathy
• B. Dilated cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Arrhythmia

Correct answer: A

Rationale: Hypertrophic cardiomyopathy is a type of heart disease characterized by the thickening or stiffening of the heart muscle, leading to a reduced ability to pump blood. This condition is different from dilated cardiomyopathy (choice B), which involves the enlargement and weakening of the heart chambers. Restrictive cardiomyopathy (choice C) is characterized by the stiffening of the heart muscle, affecting its ability to fill with blood properly. Arrhythmia (choice D) refers to abnormal heart rhythms and is not specifically related to thickening or stiffening of the heart muscle, as seen in hypertrophic cardiomyopathy.

Similar Questions